Ansell Ltd (ASX: ANN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ansell Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.05 billion
P/E Ratio 13.95
Dividend Yield 3.07%
Shares Outstanding 127.20 million
Earnings per share 1.142
Dividend per share 0.74
Year To Date Return -13.13%
Earnings Yield 7.17%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ansell Ltd (ASX: ANN)
    Latest News

    An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
    Share Market News

    Here are the top 10 ASX 200 shares today

    The ASX 200 gave investors a rough end to the week this Friday.

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why Ansell, Aurizon, Metcash, and Syrah shares are sinking today

    These ASX shares are having a tough time on Tuesday.

    Read more »

    A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
    Industrials Shares

    Why is the Ansell share price crashing 13% today?

    Here's why the Ansell share price is getting a lot of attention today.

    Read more »

    A man looks down with fright as he falls towards the ground.
    Share Fallers

    8 ASX shares that were COVID winners but have now crashed

    They were the skyrocketing ASX shares of the pandemic. But that was then...

    Read more »

    A woman sits at a table with notebook on lap and pen in hand as she gazes off to the side with the pen resting on the side of her face as though she is thinking and contemplating while a glass of orange juice and a pair of red sunglasses rests on the table beside her.
    Broker Notes

    How this fundie plans to keep investing through a recession

    There are still fears the United States could go into a recession this year.

    Read more »

    A woman looks quizzical while looking at a dollar sign in the air.
    How to invest

    My $10-a-day approach to building a second income with ASX shares

    Creating a long-term passive income doesn't have to break the bank.

    Read more »

    Broker Notes

    Morgans warns that these ASX shares could disappoint in FY23

    Investors may expecting too much from these ASX shares in the second half...

    Read more »

    a man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
    Share Market News

    6 ASX 200 directors buying up their company shares in the past week

    Are insiders hopeful of the future for these ASX 200 stocks?

    Read more »

    Young female AGL investor leans back in her desk chair feeling relieved after the AGL share price soared today
    Opinions

    I’d invest $5,000 into these excellent ASX shares for the long term

    Each of these ASX shares seem like great ideas to me.

    Read more »

    A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
    Dividend Investing

    8 ASX 200 shares trading ex-dividend this week

    Aspiring income investors better get in quick if they want a piece of these upcoming dividends.

    Read more »

    A man looks down with fright as he falls towards the ground.
    Share Fallers

    Why Ansell, Breville, Star, and Temple & Webster shares are falling

    These ASX shares are having a tough session on Tuesday and are deep in the red...

    Read more »

    Health professional putting on gloves.
    Earnings Results

    Ansell share price slumps 8% as healthcare sales fail to cough up

    It's time to put on the gloves and pick apart this doozy of a report.

    Read more »

    Frequently Asked Questions

    Yes, Ansell has historically paid two unfranked or partially franked dividends per year.

    Ansell pays its shareholder dividends in March and September.

    Ansell Ltd listed on the ASX on 22 August 1985.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    20 Feb 2023 $0.2915 0.00% Interim 09 Mar 2023
    29 Aug 2022 $0.4518 0.00% Final 15 Sep 2022
    21 Feb 2022 $0.3367 0.00% Interim 09 Mar 2022
    30 Aug 2021 $0.5944 0.00% Final 16 Sep 2021
    22 Feb 2021 $0.4190 0.00% Interim 10 Mar 2021
    31 Aug 2020 $0.3811 0.00% Final 17 Sep 2020
    24 Feb 2020 $0.3288 0.00% Interim 12 Mar 2020
    16 Aug 2019 $0.3833 0.00% Final 05 Sep 2019
    22 Feb 2019 $0.2905 0.00% Interim 14 Mar 2019
    24 Aug 2018 $0.3414 0.00% Final 13 Sep 2018
    16 Feb 2018 $0.2588 44.13% Interim 08 Mar 2018
    18 Aug 2017 $0.2998 0.00% Final 08 Sep 2017
    17 Feb 2017 $0.2638 0.00% Interim 10 Mar 2017
    19 Aug 2016 $0.3097 0.00% Final 08 Sep 2016
    11 Feb 2016 $0.2795 0.00% Interim 10 Mar 2016
    13 Aug 2015 $0.3119 0.00% Final 10 Sep 2015
    12 Feb 2015 $0.2567 0.00% Interim 11 Mar 2015
    26 Feb 2014 $0.1828 0.00% Interim 25 Mar 2014
    16 Feb 2012 $0.1050 0.00% Interim 14 Mar 2012
    17 Feb 2011 $0.0980 0.00% Interim 16 Mar 2011
    31 Aug 2010 $0.1225 0.00% Final 29 Sep 2010
    02 Mar 2006 $0.0630 0.00% Interim 07 Apr 2006
    26 Sep 2005 $0.0700 0.00% Final 18 Oct 2005

    ANN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ansell Ltd

    Ansell Ltd (ASX: ANN) is a leading global supplier of protective gloves and bodywear for use in healthcare and industrial settings.

    The company holds a large number of patents and the majority of sales come from its key branded product ranges. It earns the bulk of its revenue and profit from the healthcare segment and the remainder from its industrial business.

    The Australian company has an international manufacturing and distribution footprint and supplies its products via key partners as well as directly across more than 120 countries.

    Ansell earns the bulk of its revenue from its North American market segment followed by Europe, the Middle East, and Africa. The Asia-Pacific accounts for a relatively small portion of the company's business.

    ANN Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    09 Aug 2023 $24.24 $0.08 0.33% 372,256 $23.95 $24.32 $23.95
    08 Aug 2023 $24.16 $0.19 0.79% 220,494 $23.93 $24.22 $23.93
    07 Aug 2023 $23.97 $0.10 0.42% 164,681 $23.90 $24.17 $23.90
    04 Aug 2023 $23.87 $-0.15 -0.62% 293,056 $23.71 $23.98 $23.65
    03 Aug 2023 $24.02 $0.08 0.33% 287,773 $23.94 $24.07 $23.80
    02 Aug 2023 $23.94 $-0.41 -1.68% 201,125 $24.04 $24.25 $23.93
    01 Aug 2023 $24.35 $0.21 0.87% 205,605 $24.15 $24.41 $24.15
    31 Jul 2023 $24.14 $-0.02 -0.08% 197,939 $24.05 $24.22 $24.01
    28 Jul 2023 $24.16 $0.25 1.05% 475,809 $23.80 $24.20 $23.65
    27 Jul 2023 $23.91 $0.36 1.53% 476,680 $23.49 $23.91 $23.49
    26 Jul 2023 $23.55 $-0.09 -0.38% 219,689 $23.58 $23.64 $23.35
    25 Jul 2023 $23.64 $0.05 0.21% 274,483 $23.70 $23.83 $23.47
    24 Jul 2023 $23.59 $-0.20 -0.84% 404,734 $23.82 $24.00 $23.45
    21 Jul 2023 $23.79 $0.17 0.72% 891,231 $23.64 $24.05 $23.45
    20 Jul 2023 $23.62 $0.34 1.46% 921,069 $23.40 $24.12 $23.38
    19 Jul 2023 $23.28 $-0.60 -2.51% 1,278,638 $23.06 $23.53 $23.00
    18 Jul 2023 $23.88 $-3.89 -14.01% 2,637,724 $24.74 $24.74 $23.32
    17 Jul 2023 $27.77 $0.21 0.76% 150,158 $27.50 $27.91 $27.46
    14 Jul 2023 $27.56 $-0.03 -0.11% 239,479 $27.64 $27.75 $27.54
    13 Jul 2023 $27.59 $0.42 1.55% 404,093 $27.38 $27.78 $27.30
    12 Jul 2023 $27.17 $-0.09 -0.33% 188,495 $27.35 $27.42 $27.13
    11 Jul 2023 $27.26 $0.89 3.38% 279,383 $26.90 $27.30 $26.66

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 May 2023 John Bevan Buy 149 $3,990
    Participation in share purchase plan.
    31 May 2023 Christina Stercken Buy 227 $6,079
    Participation in share purchase plan.
    31 May 2023 Christine Yan Buy 246 $6,587
    Participation in share purchase plan.
    02 May 2023 Christina Stercken Buy 441 $11,950
    Participation in share purchase plan.
    02 May 2023 John Bevan Buy 292 $7,912
    Participation in share purchase plan.
    02 May 2023 Christine Yan Buy 480 $13,007
    Participation in share purchase plan.
    28 Feb 2023 Christine Yan Buy 228 $6,210
    Participation in share purchase plan.
    28 Feb 2023 John Bevan Buy 138 $3,758
    Participation in share purchase plan.
    28 Feb 2023 Christina Stercken Buy 210 $5,720
    Participation in share purchase plan.
    23 Feb 2023 Debra (Debbie) Goodin Buy 486 $12,959
    On-market trade.
    16 Feb 2023 John Bevan Buy 150 $3,943
    Participation in share purchase plan.
    16 Feb 2023 Christina Stercken Buy 227 $5,967
    Participation in share purchase plan.
    16 Feb 2023 Christine Yan Buy 248 $6,519
    Participation in share purchase plan.
    30 Dec 2022 Christine Yan Buy 226 $6,419
    Participation in share purchase plan.
    30 Dec 2022 Christina Stercken Buy 209 $5,936
    Participation in share purchase plan.
    30 Dec 2022 John Bevan Buy 138 $3,919
    Participation in share purchase plan.
    28 Dec 2022 Neil Salmon Issued 58 $1,654,584
    Issue of securities. 125,699 performance share rights
    30 Nov 2022 John Bevan Buy 144 $4,176
    Participation in share purchase plan.
    30 Nov 2022 Christina Stercken Buy 219 $6,351
    Participation in share purchase plan.
    30 Nov 2022 Christine Yan Buy 239 $6,931
    Participation in share purchase plan.
    31 Oct 2022 Christine Yan Buy 240 $6,715
    Participation in share purchase plan.
    31 Oct 2022 Christina Stercken Buy 221 $6,183
    Participation in share purchase plan.
    31 Oct 2022 John Bevan Buy 146 $4,085
    Participation in share purchase plan.
    30 Sep 2022 John Bevan Buy 156 $3,912
    Participation in share purchase plan.
    30 Sep 2022 Christina Stercken Buy 236 $5,918
    Participation in share purchase plan.
    30 Sep 2022 Christine Yan Buy 257 $6,445
    Participation in share purchase plan.
    08 Sep 2022 Nigel Garrard Buy 850 $22,142
    On-market trade.
    31 Aug 2022 John Bevan Buy 146 $3,838
    Participation in share purchase plan.
    31 Aug 2022 Christina Stercken Buy 222 $5,836
    Participation in share purchase plan.
    31 Aug 2022 Christine Yan Buy 241 $6,335
    Participation in share purchase plan.
    29 Aug 2022 Morten Falkenberg Buy 4 $129,937
    On-market trade.
    26 Aug 2022 Christine Yan Buy 235 $6,402
    Participation in share purchase plan.
    26 Aug 2022 Christina Stercken Buy 216 $5,885
    Participation in share purchase plan.
    26 Aug 2022 John Bevan Buy 143 $3,896
    Participation in share purchase plan.
    25 Aug 2022 Neil Salmon Exercise 39 $1,075,858
    Conversion of securities. 66,817 performance share rights
    As per announcement on 07-09-2022
    25 Aug 2022 Neil Salmon Issued 39 $1,075,858
    Conversion of securities.
    25 Aug 2022 Neil Salmon Sell 16 $454,467
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Nigel David Garrard Non-Executive Director Mar 2020
    Mr Garrard is an experienced executive with a track record across FMCG and Industrial/ Manufacturing sectors. Mr Garrard has 20 years' experience as an ASX-listed CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013.
    Mr William G Reilly Non-Executive Director Oct 2017
    Mr Reilly has over 35 years' experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002.
    Mr John Andrew Bevan Non-Executive DirectorNon-Executive Chairman Aug 2012
    Mr Bevan was formerly the Chief Executive Officer and Executive Director of Alumina Limited and brings to the Board international business experience. Prior to joining Alumina Limited, he had a long career with the BOC Group Plc, where he was a member of the Board of Directors and held senior management positions in Australia, Korea, Thailand, Singapore and the UK.
    Ms Debra (Debbie) Lyn Goodin Non-Executive Director Dec 2022
    --
    Ms Leslie A Desjardins Non-Executive Director Nov 2015
    Ms Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the US and Australia, including Chief Financial Officer GM Holden, Controller for GM North America.
    Mrs Christina Stercken Non-Executive Director Oct 2017
    Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A and operational excellence in growth markets.
    Ms Christine Yingli Yan Non-Executive Director Feb 2019
    Ms Yan is an experienced executive, She had a career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems.
    Mr Neil Salmon Chief Executive OfficerManaging Director Sep 2021
    Mr Salmon had more than 20 years of professional experience, gained working across roles in a diverse group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the USA and Singapore before serving as Chief Financial Officer of Innophos in New Jersey, USA.
    Morten Falkenberg Non-Executive Director Nov 2021
    Mr Falkenberg is a experienced and seasoned executive with 35 years of leadership experience within FMCG, Telecoms/ Technology, and consumer durable goods companies. Prior to that Mr Falkenberg held senior positions at Electrolux, Tele Denmark and Coca-Cola and has lived outside his native Denmark in the U.S., Israel, Norway and Sweden.
    Ms Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary Apr 2017
    -
    Renae Leary Chief Commercial Officer - Americas
    -
    Francois le Jeune Chief Commercial Officer - EMEA & APAC and Guardian Administration
    -
    Zubair Javeed Chief Financial Officer
    -
    Amanda Manzoni Chief Human Resources Officer
    -
    Michael Gilleece Corporate General Counsel
    -
    Deanna Johnston Global Chief Information Officer
    -
    Darryl Nazareth President HGBU
    -
    Rikard Froberg President IGBU
    -
    Augusto Accorsi SBU Vice President & GM HGBU Exam & Single Use
    -
    Angie Phillips SBU Vice President & GM HGBU Surgical & HSS
    -
    Paul Bryce SBU Vice President & GM IGBU Chemical Solutions
    -
    Sean Sweeney SBU Vice President & GM IGBU Mechanical Solutions
    -
    John Marsden Senior Vice President = Global Operations and Global Supply Chain
    -
    Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 32,838,929 25.80%
    J P Morgan Nominees Australia Pty Limited 18,304,332 14.38%
    Citicorp Nominees Pty Limited 18,200,942 14.30%
    National Nominees Limited 4,514,901 3.55%
    BNP Paribas Noms Pty Ltd <Drp> 3,512,957 2.76%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 2,532,328 1.99%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Ltd <Drp A/C> 1,485,653 1.17%
    CPU Share Plans Pty Ltd <Psr Nor Unallocated A/C> 1,399,288 1.10%
    Australian Foundation Investment Company Limited (i) 1,078,865 0.85%
    Netwealth Investments Limited <Wrap Services A/C> 637,660 0.50%
    HSBC Custody Nominees (Australia) Limited A/C 2 517,669 0.41%
    Australian Executor Trustees Limited <IPS IOOF Employer Super A/C> 363,766 0.29%
    Netwealth Investments Limited <Super Services A/C> 350,499 0.28%
    Custodial Services Limited <Beneficiaries Holding A/C> 331,105 0.26%
    Australian Executor Trustees Limited <No 1 Account> 320,262 0.25%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 306,042 0.24%
    Australian Foundation Investment Company Limited (ii) 290,000 0.23%
    Citicorp Nominees Pty Limited <Citibank NY ADR Dep A/C> 288,540 0.23%
    BNP Paribas Nominees Pty Ltd <Pitcher Partners DRP> 254,087 0.20%
    Mirrabooka Investments Limited 235,000 0.18%

    Profile

    since

    Note